Compound information
- Natural Products
- ZC1252648
- Molecular Formula
- C18H22N4O
- Molecular Weight
- 310.179361324 g/mol
- Structure
-
- IUPAC Name
- 4-benzyl-N-(3-pyridyl)-1,4-diazepane-1-carboxamide
- InChI
- InChI=1S/C18H22N4O/c23-18(20-17-8-4-9-19-14-17)22-11-5-10-21(12-13-22)15-16-6-2-1-3-7-16/h1-4,6-9,14H,5,10-13,15H2,(H,20,23)
- InChI Key
- DOTAUCHUCBDFGH-UHFFFAOYSA-N
- SMILES
- O=C(Nc1cccnc1)N1CCCN(Cc2ccccc2)CC1
- Source
- ZINC000044890943
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 3 |
Heteroatom Count | 5 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 48.47 Å2 | LogP | 2.05 |
LogS | -2.556 | LogD | 2.245 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.052 | Pgp substrate | 0.346 |
HIA | 0.954 | F20 % | 0.922 |
F30 % | 0.343 | Caco-2 | -4.893 |
MDCK | -4.957 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.846 | PPB | 62.407 |
VD | 1.19 | Fu | 0.679 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.075 | CYP1A2 substrate | 0.726 |
CYP2A6 substrate | 0.857 | CYP2B6 substrate | 0.8 |
CYP2C19 inhibitor | 0.647 | CYP2C19 substrate | 0.733 |
CYP2C8 substrate | 0.76 | CYP2C9 inhibitor | 0.674 |
CYP2C9 substrate | 0.223 | CYP2D6 inhibitor | 0.932 |
CYP2D6 substrate | 0.999 | CYP2E1 substrate | 0.703 |
CYP3A4 inhibitor | 0.265 | CYP3A4 substrate | 0.957 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.836 | CL | 12.37 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.604 | Hepatotoxicity | 0.239 |
Mutagenicity | 0.0 | Rat Oral Acute Toxicity | 0.783 |
FDAMDD | 0.38 | Skin Sensitization | 0.973 |
Carcinogenicity | 0.008 | Eye Corrosion | 0.001 |
Eye Irritation | 0.007 | Respiratory Toxicity | 0.965 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.245 | IGC50 | 3.388 |
LC50FM | 2.226 | LC50DM | -2.512 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.387 | NR-AR-LBD | 0.192 |
NR-AhR | 0.654 | NR-Aromatase | 0.021 |
NR-ER | 0.358 | NR-ER-LBD | 0.306 |
NR-PPAR-gamma | 0.155 | SR-ARE | 0.825 |
SR-ATAD5 | 0.381 | SR-HSE | 0.175 |
SR-MMP | 0.02 | SR-p53 | 0.045 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.